Title: United States Influenza Vaccines Market Size, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2031
1(No Transcript)
2United States Influenza Vaccines Market 2023 -
2031
- The influenza vaccines market in the United
States was valued at US 3,962 million in 2022
and is expected to reach US 8,347 million by
2031, registering a CAGR of 8.6 during the
forecast period.
- Rapid market expansion is primarily due to
increased research and development, the
introduction of quadrivalent influenza vaccines,
the aging population, and vaccine awareness. In
addition, expanded recommendations from
government and advisory bodies to get influenza
vaccines are driving market growth in the United
States.
3United States Influenza Vaccines Market 2023 -
2031
Influenza is the second leading cause of death
from vaccine-preventable disease in the United
States after COVID-19. Rates of seasonal
influenza infection are highest in children, but
the risks for complications, hospitalizations,
and deaths are higher in adults 65 years of age
and older, children younger than 5 years,
pregnant women, and people of any age with
conditions that place them at increased risk for
influenza complications.
4United States Influenza Vaccines Market 2023 -
2031
More Details _at_ https//dpiresearch.com/united-st
ates-influenza-vaccines-market-2023/ Contact
Us Maria Rai Head of Business Development DPI
Research Direct Line 91-766-764-8693 E-mail
sales_at_dpiresearch.com